Tag:
HVC-796
Latest Headlines
Latest Headlines
Wyeth, ViroPharma drops Hep C drug
After observing serious safety problems in a Phase II trial, Wyeth and ViroPharma are dropping development of HCV-796. In August the companies halted study of the drug when the data showed elevated
